Navigation Links
Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
Date:5/7/2008

compounds target G protein-coupled receptors, an important class of validated drug targets, and includes compounds being evaluated independently and with partners, including Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the continuation of the collaboration between Arena and Taisho and efforts thereunder; the progress of a Phase 1 clinical trial program under such collaboration, including future results, activities and related payments; the therapeutic, commercial and other potential of the compound in such clinical trial program; and other statements about Arena's outlook, strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, clinical trials and studies may not proceed at the time or in the manner Arena expects or at all, the results of clinical trials or preclinical studies may not be predictive of future results, Arena's ability to partner lorcaserin, APD125, APD791 or other of its compounds or programs, the timing, success and cost of Arena's research, out-licensing endeavors and clinical trials, Arena's ability to obtain additional financing, Arena's ability to obtain and defend its patents, the timing and receipt of payments and fees, if any, from Arena's collaborators, and Arena's ability to redeem with common stock any outstanding
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
10. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
11. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 2014  Diomics, Inc., provider of X-Swab™, a ... United States Patent and Trademark Office has issued ... biologic sample collection materials, devices made from them, ... diagnostics. The primary method of ... of DNA from a number of commercially-available swabs ...
(Date:7/14/2014)... , July 14, 2014  Otonomy, Inc., a ... of innovative therapeutics for diseases and disorders of the ... publicly filed a registration statement on Form S-1 with ... a proposed initial public offering of shares of its ... sold in the offering will be offered by Otonomy. ...
(Date:7/14/2014)... -- Mylan Inc. (NASDAQ: MYL ) today announced that ... Abbott (NYSE: ABT ) whereby Mylan ... specialty and branded generics business ("the Assets") in an all-stock ... 105 million shares of the combined company worth approximately $5.3 ... July 11, 2014, representing an approximately 21% ownership stake. The ...
Breaking Medicine Technology:Diomics Announces Issuance Of U.S. Patents For Novel Biologic Sample DNA Collection Materials For Use In Forensics And Diagnostics 2Otonomy Files Registration Statement for Proposed Initial Public Offering 2Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 2Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 3Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 4Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 5Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 6Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 7Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 8Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 9Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 10Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 11
... New England, many providers of durable medical equipment and services ... to the havoc created by Hurricane Irene.  Of particular concern ... for people who require a ventilator for breathing ... other lung diseases or chronic heart failure.   ...
... Pa., Sept. 2, 2011 VWR International, LLC, a ... today that it has acquired INTERNATIONAL P.B.I. S.p.A., based ... INTERNATIONAL P.B.I. is a leading supplier for laboratory equipment ... expertise in the microbiology field.  The Company represents several ...
Cached Medicine Technology:Hurricane Irene Spurs Emergency Home Medical Services for Patients 2Hurricane Irene Spurs Emergency Home Medical Services for Patients 3Hurricane Irene Spurs Emergency Home Medical Services for Patients 4VWR International, LLC Acquires INTERNATIONAL P.B.I. S.p.A. 2
(Date:7/14/2014)... Clearwater, Florida (PRWEB) July 14, 2014 ... Summer Open House event will be held at the ... Wednesday July 16th from 4-8pm. Wine and other refreshments ... advantage of retail discounts on beauty products ... skin treatment known as dermaplaning. , Dermaplaning (also ...
(Date:7/14/2014)... SUNDAY, July 13, 2014 (HealthDay News) -- Along with ... people with Alzheimer,s disease and other types of dementia, ... their quality of life, the researchers said. "These ... variety of benefits for people with dementia and their ... Lerner, of Case Western Reserve University and University Hospitals ...
(Date:7/14/2014)... HealthDay Reporter SUNDAY, July ... a faltering sense of smell might signal the early ... smell test could spot who needs more extensive screening ... ability to identify odors was associated with the loss ... "We,re trying to be able to diagnose Alzheimer,s ...
(Date:7/14/2014)... -- Stress can slow a woman,s metabolism and lead to ... women, average age 53, who were asked about their stress ... included 930 calories and 60 grams of fat. The Ohio ... to burn off those calories and fat. On average, ... previous 24 hours burned 104 fewer calories in the seven ...
(Date:7/14/2014)... Norton HealthDay Reporter MONDAY, ... mentally stimulating games may have bigger brains and sharper thinking ... looked at the connection between playing games such as puzzles, ... their 50s and 60s. Researchers found that people who ... on tests of memory and other mental functions. And, based ...
Breaking Medicine News(10 mins):Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 2Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 3Health News:Cataract Surgery a Plus for Someone With Dementia, Study Says 2Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 2Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 3Health News:Stress May Leave You Heading to the Cookie Jar 2Health News:Can Games, Puzzles Keep Aging Minds Sharp? 2Health News:Can Games, Puzzles Keep Aging Minds Sharp? 3
... , WASHINGTON, Aug. 28 The Catholic Health Association ... goal of health coverage for all people in the United States. ... consideration. , , "Our message has always been ... of the association. "Health care must respect and protect human dignity ...
... psyllium seems to ease symptoms, study finds , FRIDAY, Aug. ... as irritable bowel syndrome may find relief by consuming ... and perhaps more bowel upset -- from bran, a new ... and irregular bowel habits, affects about one in 10 Americans. ...
... continues to grow and expand even in adulthood. Just ten years ... we no longer remember when we heard this word for the ... new words become just as familiar to us as words we ... Academy of Finland,s Neuroscience Research Programme (NEURO) is how the process ...
... new pandemic flu virus creates a surge of patients ... to protect health care workers given their important role ... impact. Respiratory Protection for Healthcare Workers in the Workplace ... the Institute of Medicine, recommends the best means to ...
... , , MINNEAPOLIS, Aug. 28 ... loss contest where three big losers can enjoy big prizes, including ... makeover and a $500 shopping spree. , , ... than 30 years--and we,ve seen what a huge impact losing a ...
... Aug. 28 /PRNewswire-FirstCall/ - Hard to Treat Diseases (the "Company") ... the beginning of August, 2009, Mellow Hope transported another 46,000 ... third batch of this year. After the launch of Hepatitis ... market share keeps growing steadily for HTDS and the product ...
Cached Medicine News:Health News:Catholic Health Association Reaffirms Long-Standing Commitment to Reform Health Care But Waits to Endorse Any Specific Bill 2Health News:Soluble Fiber, But Not Bran, Soothes Irritable Bowel 2Health News:Familiar and newly learned words are processed by the same neural networks in the brain 2Health News:Now Three Big Losers Can Win Big With New OPTIFAST(R) Weight Loss Contest 2Health News:Hard To Treat Diseases (HTDS.PK) - 46,000 India Doses of Hepatitis A 2
Calculate accurate growth percentiles and Z scores using the latest CDC growth charts....
PDA-version of the leading portable drug reference....
PDA application containing all 7,000+ Physicians' Current Procedural Terminology codes developed by the American Medical Association....
More than 200 key diagnostic and treatment tables culled from Tierney's Current Medical Diagnostics and Treatment 2003....
Medicine Products: